News & Events - Momentum Biotechnologies

May 27, 2026

•New Service

Momentum Biotechnologies Launches CHIPP, A Novel High-Throughput Target Deconvolution Technology

Momentum Biotechnologies ("Momentum"), a contract research organization that leverages mass spectrometry for drug discovery, announced today the launch of CHIPP (chaotrope-induced protein precipitation and proteome profiling), a novel, sensitive, scalable, and label-free assay for the analysis of drug:target interactions. This technology enables the automated, proteome-wide profiling of hundreds of test compounds, harnessing the analytical capacity of mass spectrometry for target identification, deconvolution, and selectivity profiling. "We are very excited to launch our new CHIPP...

May 28, 2025

•SAB

Billerica, MA and Freising, Germany

Momentum Biotechnologies Expands Scientific Advisory Board with Two New Additions

Momentum Biotechnologies ("Momentum"), a contract research organization specializing in mass spectrometry-based drug discovery and proteomics, announced today the appointment of two new members to its Scientific Advisory Board ("SAB"): Dr. Bernhard Küster and Dr. Mathias Wilhelm. Both are professors at the Technical University of Munich ("TUM") and co-founders of OmicScouts, a proteomics service provider recently acquired by Momentum (now operating as OmicScouts, A Momentum Biotechnologies Company). "We are proud to add these two renowned scientists to our scientific advisory board," says...

March 4, 2025

•Acquisition

Billerica, MA and Freising, Germany

Momentum Biotechnologies Announces Acquisition of OmicScouts

https://vimeo.com/1071860408 Momentum Biotechnologies (“Momentum”), a contract research organization (“CRO”) specializing in mass spectrometry-based drug...

August 8, 2024

•Partnerships

Billerica, MA and Monheim, Germany

Momentum Biotechnologies and Cube Biotech Announce Strategic Partnership

Momentum Biotechnologies, an innovative contract research organization ("CRO") for mass spectrometry-based drug discovery, and Cube Biotech, a leader in...

November 29, 2023

•New Service

Billerica, MA

Momentum Biotechnologies Launches Proteomics as New Service Offering

Momentum Biotechnologies, a leading provider of mass spectrometry-based analytical drug discovery services, has announced the launch of new services focused on...

November 16, 2023

•Partnerships

Billerica, MA and Milan, Italy

Momentum Biotechnologies and Axxam S.p.A. Announce Collaboration to Provide Unique Drug Discovery Solutions

Axxam S.p.A. and Momentum Biotechnologies have announced a partnership to provide unique drug discovery solutions for biotechnology and pharmaceutical clients....

September 13, 2023

•SAB

Billerica, MA

Momentum Biotechnologies Welcomes Former Merck Bioanalytical VP Dr. Kevin Bateman to its Scientific Advisory Board

Momentum Biotechnologies (“Momentum” or the “Company”), a leading contract research organization (“CRO”) specializing in mass spectrometry-based native...

August 28, 2023

•SAB

Billerica, MA

Momentum Biotechnologies Welcomes Harvard Medical School Professor Dr. Ying Lu to its Scientific Advisory Board

Momentum Biotechnologies (“Momentum” or the “Company”), a leading contract research organization (“CRO”) specializing in mass spectrometry-based native...

February 24, 2023

•Other News

Billerica, MA

PureHoney Technologies Announces Rebranding to Momentum Biotechnologies to Better Reflect Its Mission

Momentum Biotechnologies, formerly known as PureHoney Technologies, is a leading CRO focused on providing mass spectrometry-based native detection technologies...

October 22, 2021

•Other News

Billerica, MA

PureHoney Technologies Relocates to a New Headquarters and Research Facility

PureHoney Technologies (PHT) has moved to a new 20,000 SF headquarters and research facility located at 3 Federal St., Suite 300, Billerica, MA 01821. The...

Sort By

Filter By